Evolution of hepatic encephalopathy over time: ecological data from a tertiary referral centre for hepatology

被引:3
作者
Mangini, C. [1 ]
Zarantonello, L. [1 ]
Formentin, C. [1 ]
Giusti, G. [1 ]
Angeli, P. [1 ]
Montagnese, S. [1 ,2 ]
机构
[1] Univ Padua, Dept Med, Via Giustiniani, I-35128 Padua, Italy
[2] Univ Surrey, Fac Hlth & Med Sci, Chronobiol Sect, Guildford, England
关键词
PHES; EEG; Ammonia-lowering treatment; Portal-systemic shunt; PROGNOSTIC-SIGNIFICANCE; CIRRHOSIS; RISK;
D O I
10.1016/j.dld.2022.06.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Few data on hepatic encephalopathy (HE) over time are available, thus our aim was to study its evolution in patients with varying degree of HE on first assessment.Methods: Eighty-six patients with cirrhosis (age = 58 +/- 11 years; males = 72) were evaluated 2-10 times for liver transplantation selection purposes, differential diagnosis or treatment optimization. The presence/severity of HE was assessed by clinical and neuropsychiatric indices [ Psychometric Hepatic En-cephalopathy Score (PHES) and electroencephalography (EEG)] and the severity of liver disease by the Model for End-Stage Liver Disease (MELD) score. Treatment was instituted/modified after each evalua-tion.Results: Amongst 23 unimpaired patients, 56/6% remained unimpaired, 35/3% developed covert HE, 9/0% developed overt HE on second/third evaluation. Amongst 32 patients with covert HE, 25/10% became unimpaired, 44/19% remained covert, 31/13% developed overt HE. Finally, amongst 32 patients with overt HE, 19/16% became unimpaired, 25/13 % became covert and 56/25% remained overt. PHES results im -proved in patients with overt HE and EEG worsened over time (despite remaining normal) in unimpaired patients. In patients with multiple evaluations, HE evolution was manifold and difficult to predict.Conclusions: HE evolution over time is variable and largely dependent on HE history/management. These data support the concept that HE is an essentially reversible condition.(c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:93 / 98
页数:6
相关论文
共 32 条
[21]   Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease [J].
Ochoa-Sanchez, Rafael ;
Rose, Christopher F. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) :262-271
[22]  
PARSONSSMITH BG, 1957, LANCET, V2, P867
[23]   Covert Hepatic Encephalopathy Is Independently Associated With Poor Survival and Increased Risk of Hospitalization [J].
Patidar, Kavish R. ;
Thacker, Leroy R. ;
Wade, James B. ;
Sterling, Richard K. ;
Sanyal, Arun J. ;
Siddiqui, Mohammad S. ;
Matherly, Scott C. ;
Stravitz, R. Todd ;
Puri, Puneet ;
Luketic, Velimir A. ;
Fuchs, Michael ;
White, Melanie B. ;
Noble, Nicole A. ;
Unser, Ariel B. ;
Gilles, HoChong ;
Heuman, Douglas M. ;
Bajaj, Jasmohan S. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (11) :1757-1763
[24]   Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy [J].
Riggio, Oliviero ;
Ridola, Lorenzo ;
Pasquale, Chiara ;
Nardelli, Silvia ;
Pentassuglio, Ilaria ;
Moscucci, Federica ;
Merli, Manuela .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (02) :181-183
[25]  
RIKKERS L, 1978, GASTROENTEROLOGY, V75, P462
[26]   Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy [J].
Romero-Gómez, M ;
Boza, F ;
García-Valdecasas, MS ;
García, E ;
Aguilar-Reina, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (09) :2718-2723
[27]   Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo [J].
Sharma, Barjesh Chander ;
Sharma, Praveen ;
Agrawal, Amit ;
Sarin, Shiv Kumar .
GASTROENTEROLOGY, 2009, 137 (03) :885-891
[28]  
SHERLOCK S, 1954, LANCET, V2, P453
[29]  
Tan HH, 2009, SINGAP MED J, V50, P255
[30]   OBJECTIVE MEASUREMENT OF HEPATIC-ENCEPHALOPATHY BY MEANS OF AUTOMATED EEG ANALYSIS [J].
VANDERRIJT, CCD ;
SCHALM, SW ;
DEGROOT, GH ;
DEVLIEGER, M .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1984, 57 (05) :423-426